Literature DB >> 18554369

Antiplatelet cilostazol, an inhibitor of type III phosphodiesterase, improves swallowing function in patients with a history of stroke.

Shinji Teramoto, Hiroshi Yamamoto, Yasuhiro Yamaguchi, Masaki Ishii, Shinichiro Hibi, Haruki Kume, Yasuyoshi Ouchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18554369     DOI： 10.1111/j.1532-5415.2008.01703.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  4 in total

Review 1.  Healthcare-associated Pneumonia and Aspiration Pneumonia.

Authors:  Kosaku Komiya; Hiroshi Ishii; Jun-Ichi Kadota
Journal:  Aging Dis       Date:  2014-02-08       Impact factor: 6.745

Review 2.  Pharmacotherapy and the Role of Pharmacists in Rehabilitation Medicine.

Authors:  Yoshihiro Yoshimura; Ayaka Matsumoto; Ryo Momosaki
Journal:  Prog Rehabil Med       Date:  2022-05-14

3.  Swallowing therapy for dysphagia in acute and subacute stroke.

Authors:  Philip M Bath; Han Sean Lee; Lisa F Everton
Journal:  Cochrane Database Syst Rev       Date:  2018-10-30

Review 4.  Cilostazol for the prevention of pneumonia: a systematic review.

Authors:  Hirotaka Nakashima; Kazuhisa Watanabe; Hiroyuki Umegaki; Yusuke Suzuki; Masafumi Kuzuya
Journal:  Pneumonia (Nathan)       Date:  2018-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.